EX-1
from SCHEDULE 13G
~1
page
Joint Filing Agreement Trails Edge Capital Partners, LP By: Trails Edge Capital Partners, LLC, the General Partner of Trails Edge Capital Partners, LP By: /S/ Ortav Yehudai Name: Ortav Yehudai Title: Chief Investment Officer Trails Edge Biotechnology Master Fund, LP By: Trails Edge GP, LLC, the General Partner of Trails Edge Biotechnology Fund GP, LP, the General Partner of Trails Edge Biotechnology Master Fund, LP By: /S/ Ortav Yehudai Name: Ortav Yehudai Title: Chief Investment Officer Ortav Yehudai /S/ Ortav Yehudai
12/34/56
EX-1.1
from 8-K
45 pages
X4 Pharmaceuticals, Inc. 52,300,000 Shares of Common Stock Pre-Funded Warrants to Purchase 6,800,000 Shares of Common Stock Class C Warrants to Purchase 29,550,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K
50 pages
X4 Pharmaceuticals, Inc. 3,666,667 Shares of Common Stock Pre-Funded Warrants to Purchase 1,750,000 Shares of Common Stock Class B Warrants to Purchase 5,416,667 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K
49 pages
X4 Pharmaceuticals, Inc. 5,670,000 Shares of Common Stock Pre-Funded Warrants to Purchase 2,130,000 Shares of Common Stock Class a Warrants to Purchase 3,900,000 Shares of Common Stock Underwriting Agreement
12/34/56